rs104894820
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 6P and 4B. PM1PP3_StrongBS2
The NM_000166.6(GJB1):c.37G>A(p.Val13Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,208,459 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000166.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GJB1 | NM_000166.6 | c.37G>A | p.Val13Met | missense_variant | 2/2 | ENST00000361726.7 | NP_000157.1 | |
GJB1 | NM_001097642.3 | c.37G>A | p.Val13Met | missense_variant | 2/2 | NP_001091111.1 | ||
GJB1 | XM_011530907.3 | c.37G>A | p.Val13Met | missense_variant | 2/2 | XP_011529209.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GJB1 | ENST00000361726.7 | c.37G>A | p.Val13Met | missense_variant | 2/2 | 1 | NM_000166.6 | ENSP00000354900.6 |
Frequencies
GnomAD3 genomes AF: 0.0000538 AC: 6AN: 111534Hom.: 0 Cov.: 23 AF XY: 0.0000593 AC XY: 2AN XY: 33740
GnomAD3 exomes AF: 0.0000602 AC: 11AN: 182766Hom.: 0 AF XY: 0.0000297 AC XY: 2AN XY: 67404
GnomAD4 exome AF: 0.0000164 AC: 18AN: 1096925Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 5AN XY: 362319
GnomAD4 genome AF: 0.0000538 AC: 6AN: 111534Hom.: 0 Cov.: 23 AF XY: 0.0000593 AC XY: 2AN XY: 33740
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease X-linked dominant 1 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | DASA | Feb 14, 2022 | The c.37G>A;p.(Val13Met) missense variant has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 637129; PMID: 22944031) - PS4_moderate. The variant is located in a mutational hot spot and/or critical and well-established functional domain (Connexin) - PM1. The variant is present at low allele frequencies population databases (rs104894820 - gnomAD 0.0006019%; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2_supporting. Pathogenic missense variant in this residue have been reported (ClinVar ID: 10439 - c.37G>T;p.(Val13Leu); PMID: 27544631 - p.(Val13Glu)) - PM5. Multiple lines of computational evidence support a deleterious effect on the gene or gene product - PP3. In summary, the currently available evidence indicates that the variant is likely pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
Charcot-Marie-Tooth disease Uncertain:1
Uncertain significance, flagged submission | literature only | Inherited Neuropathy Consortium | - | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2020 | The p.V13M variant (also known as c.37G>A), located in coding exon 1 of the GJB1 gene, results from a G to A substitution at nucleotide position 37. The valine at codon 13 is replaced by methionine, an amino acid with highly similar properties. This alteration has been detected in a small number of individuals who are described as carrying a diagnosis of Charcot-Marie-Tooth neuropathy (Bone LJ et al. Neurobiol Dis, 1997;4:221-30; Liu L et al. Clin Genet, 2017 Jun;91:881-891; Panosyan FB et al. Neurology, 2017 Aug;89:927-935). Based on data from gnomAD, the A allele has an overall frequency of 0.006% (11/182,766) total alleles studied, with 2 hemizygotes observed. The highest observed frequency was 0.033% (9/27,415) of Latino alleles. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Charcot-Marie-Tooth Neuropathy X Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 09, 2023 | - - |
not provided Benign:1
Likely benign, no assertion criteria provided | provider interpretation | Inherited Neuropathy Consortium | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at